Managing bowel obstruction in ovarian cancer using a percutaneous endoscopic gastrostomy (PEG) tube
Abstract
An estimated 2,500 women were diagnosed with and 1,500 died from ovarian cancer in Canada in 2002. Up to 42% of patients in the palliative phase develop a malignant bowel obstruction. Options for management include medical therapy, surgery, and/or a percutaneous endoscopic gastrostomy (PEG) tube.
The objective of this quality improvement study was to: 1) examine if successful palliation was achieved using a PEG tube, and 2) identify opportunities to improve the quality of nursing care provided. A retrospective review of 24 patient records revealed that 75% did not have nausea/vomiting by time of discharge; 92% resumed a clear fluid diet; 83% were discharged from the acute care setting; and 70% did not require re-admission. A PEG tube may effectively palliate women with non-operable bowel obstruction in advanced/recurrent cancer of the ovary. Opportunities for improving care are presented.
Full Text:
PDFReferences
Abu-Rustum, N., Barakat, R.R., Venkatramann, E., & Spriggs, D.
(1997). Chemotherapy and total parenteral nutrition for advanced
ovarian cancer with bowel obstruction. Gynecologic Oncology,
, 493-495.
Adelson, M.D., & Kasowitz, M.H. (1993). Percutaneous endoscopic
drainage gastrostomy in the treatment of gastrointestinal
obstruction from intraperitoneal malignancy. Obstetrics &
Gynecology, 81(3), 467-471.
Baumrucker, S. (1998). Management of intestinal obstruction in
hospice care. The American Journal of Hospice & Palliative
Care, 232-235.
Beattie, G., Leonard, R.C.F., & Smyth, J.F. (1989). Bowel obstruction
in ovarian carcinoma: A retrospective study and review of the
literature. Palliative Medicine, 3, 275-280.
Cain, J., Wenzel, L., Monk, B., & Cella, D. (1998). Palliative care and
quality of life. In D.M. Gershenson & W.P. McGuire (Eds.),
Ovarian cancer: Controversies in management (pp. 281-303).
Edinburgh, Scotland: Churchill Livingston.
DiScia, P.J., & Creasman, W.T. (2002). Epithelial ovarian cancer.
Clinical gynecologic oncology (pp. 289-343). St. Louis, MO:
Mosby.
Fainsinger, R.L., Spachynski, K., Hanson, J., & Bruera, E. (1994).
Symptom control in terminally ill patients with malignant bowel
obstruction. Journal of Pain and Symptom Management, 9(1),
-18.
Feuer, D.J., Broadley, K.E., & Barton, D.P.J. (2000). Surgery for the
resolution in malignant bowel obstruction in advanced
gynecological and gastrointestinal cancer. Cochrane Database of
Systematic Reviews, 4, CD002764.
Frankel Kelvin, J., & Scagliola, J. (1998). Metastases involving the
gastrointestinal system. Seminars in Oncology Nursing, 14(3),
-198.
Gadducci, A., Iacconi, I., Fanucchi, A., Cosio, S., Miccoli, P., &
Genazzani, A.R. (1998). Survival after intestinal obstruction in
patients with fatal ovarian cancer: Analysis of prognostic variables.
International Journal of Gynecological Cancer, 8, 177-182.
Gemlo, B., Rayne, A.A., Lewis, B., Wong, A., Viele, C.S., Ungaretti,
J.R., et al. (1986). Home support of patients with end-stage
malignant bowel obstruction using hydration and venting
gastrostomy. The American Journal of Surgery, 152, 100-104.
Hopkins, M.P., Roberts, J.A., & Morley, G.W. (1987).
Outpatient management of small bowel obstruction in
terminal ovarian cancer. The Journal of Reproductive
Medicine, 32(11), 827-829.
Jong, P., Sturgeon, J., & Jamieson, C.G. (1995). Benefit of palliative
surgery for bowel obstruction in advanced ovarian cancer.
Canadian Journal of Surgery, 5, 454-457.
Kehoe, S., & Mann, C. (2002). Role of surgery in relapse and
palliation of ovarian cancer. In I. Jacobs, J. Shepherd, D. Oram, A.
Blackett, D. Luesley, A. Berchuck, & C. Hudson (Eds.), Ovarian
cancer, (pp. 305-309). Oxford, England: Oxford University Press.
Khoo, D., Hall, E., Motson, R., Riley, J., Denman, K., & Waxman, J.
(1994). Palliation of malignant intestinal obstruction using
Octriotide. European Journal of Cancer, 30A, 28-30.
Malone, J.M., Koonce, T., Larson, D.M., Freedman, R.S., Carrasco,
C.H.O., & Saul, P.B. (1986). Palliation of small bowel obstruction
by percutaneous gastrostomy in patients with progressive ovarian
carcinoma. Obstetrics & Gynecology, 68(3), 431-433.
Mangili, G., Franchi, M., Mariani, A., Zanaboni, F., Rabaitti, E.,
Frigerio, L., et al. (1996). Octriotide in the management of bowel
obstruction in terminal ovarian cancer. Gynecologic Oncology,
, 345-348.
Marks, W., Perkal, M.F., & Schwartz, P.E. (1993). Percutaneous
endoscopic gastrostomy for gastric decompression in metastatic
gynecologic malignancies. Surgery, Gynecology and Obstetrics,
, 573-576.
Mercandante, S., Spoldi, E., Caraceni, A., Maddaloni, S., &
Simonetti, M.T. (1993). Octriotide in relieving gastrointestinal
symptoms due to bowel obstruction. Palliative Medicine, 7,
-299.
National Cancer Institute of Canada. (2002). Canadian cancer
statistics 2002. Toronto: Author.
Ripomonti, C. (1994). Management of bowel obstruction in advanced
cancer. Current Opinion in Oncology, 6, 351-357.
van Ooijen, B., van der Burg, M.E.L., Planting, A.S.Th., Siersema,
P.D., & Wiggers, T. (1993). Surgical treatment or gastric drainage
only for intestinal obstruction in patients with carcinoma of the
ovary or peritoneal carcinomatosis of other origin. Surgery,
Gynecology and Obstetrics, 176, 469-474.
Refbacks
- There are currently no refbacks.


